Global Bronchitis Treatment Market 2020-2026
発行: Orion Market Research Pvt Ltd
世界の気管支炎治療の市場は予測期間中にかなりの成長を示すと予測されています。高齢者人口の増加や大気汚染から、喘息および慢性閉塞性肺疾患 (COPD) の有病率が増加しており、これらの要因が同市場の成長を推進しています。薬剤区分の中では、気管支拡張薬が予測期間中に高いCAGRを示す見通しです。地域別では、北米地域が大きなシェアを占めると予測されており、高度に成熟し開発された医療インフラを持つ米国は高度な治療ソリューションの開発に貢献しています。また、総人口の増加、高齢者人口の増加、工業化の加速とそれに伴う大気汚染のレベルが上昇などの要因から、アジア太平洋地域が予測期間中、高い成長率を示す見通しです。
Global Bronchitis Treatment Market Size, Share & Trends Analysis Report by Type (Drugs (Antibiotics, Anti-Inflammatory Drugs, Bronchodilators, and Others) and Oxygen Therapy) and Forecast 2020-2026
The global bronchitis treatment market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the rising geriatric population and air pollution, which in turn, is increasing the prevalence of asthma and chronic obstructive pulmonary disease (COPD) across the globe. With the rise in these respiratory diseases, the incidence rate of bronchitis increases, which in turn, is offering growth to the market across the globe. The bronchitis treatment market is classified on the basis of type of treatment, which includes drugs and oxygen therapy. The drugs segment is further segregated into antibiotics, anti-inflammatory drugs, bronchodilators, and others. Among these types of treatments, the drugs find its significant application in the bronchitis treatment across the globe. In addition, the bronchodilator is estimated to project a considerable CAGR during the forecast period.
Geographically, the global bronchitis treatment market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute a significant share in the global market. The US with a highly matured and developed healthcare infrastructure, contributes to the development of advanced treatment solution for bronchitis. The US has a high spending on healthcare R&D and high prevalence of asthma, which in turn, offers growth to the bronchitis treatment market in North America. In addition, Asia-Pacific is expected to project a considerable growth during the forecast period. This growth is backed by the rising population leading to the rise in geriatric population and increase in industrial sector in the region, especially in India, China, South Korea, and Japan. With the rise in industrialization, the level of air pollution will rise, which in turn, will augment the growth of the bronchitis treatment market in Asia-Pacific.
The global bronchitis treatment market is influenced by product development and advancements conducted by the market players. The key players of the bronchitis treatment market include Abbott Laboratories, Bayer AG, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. These players are playing a significant role in the growth of the bronchitis treatment market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.
The market study of the global bronchitis treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary sources include:
The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
The Report Covers: